Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Episode Summary

EP326: Conference Time

Dr. Warwick Bishop hosts this episode, sharing his experiences and key learnings from the NCC (National Cardiac) Congress held in Sydney on March 2-3, 2024. The episode features detailed insights from world-renowned cardiologists and specialists who presented on cutting-edge cardiac care, including genetic risk assessment, new cholesterol-lowering therapies, women's cardiovascular health, heart failure management, and innovative approaches to rural healthcare delivery.

Key Takeaways:

• Holistic patient care is essential—specialists must look beyond their particular expertise to address all aspects of a patient's health, including blood pressure, diabetes, weight, mental health, and general well-being.

• Polygenic risk scores could help stratify patients for earlier screening; rather than using fixed age-based imaging protocols, genetic risk scores could identify which age groups need arterial imaging (e.g., imaging high-risk individuals at 35 versus standard protocols at 50+).

• Research suggests a potential link between LDL particles and amyloid protein, indicating that cardiovascular health and brain health are interconnected and deserve integrated research and treatment approaches.

• Small interfering RNA (siRNA) molecules represent an exciting breakthrough in treating dyslipidemia, with potential applications expanding to triglycerides, lipoprotein A, and even hypertension management.

• siRNA therapies can be administered every 6-12 months with prolonged cellular effects, dramatically improving medication adherence and treatment efficacy compared to daily medications.

• Women receive better cardiovascular outcomes when treated by female physicians, yet women's heart disease remains under-researched and under-resourced globally, with insufficient female cardiologists in the field.

• Ventricular assist devices (mechanical pumps) for heart failure have advanced significantly, with the longest recorded use reaching 18 years, and success depends on maximizing guideline-directed medical therapy including beta-blockers and SGLT2 inhibitors.

• Mobile cardiac clinics (like the Heart of Australia Truck) effectively bring specialized cardiovascular care to remote rural areas, identifying high-risk patients who would otherwise lack access to screening and intervention.

• Lipoprotein A is approximately six times more atherogenic than standard LDL cholesterol and represents a significant cardiovascular risk factor requiring targeted management strategies.

• Social media presents a double-edged sword for medical communication—while it enables patient engagement with quality health information, it also exposes clinicians to potential misinformation and malicious attacks.